Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Dyslipidemia

Free Subscription Articles published in N Engl J Med Retrieve available abstracts of 24 articles: HTML format

Single Articles

July 2021
1. BJORNSTAD P, Drews KL, Caprio S, Gubitosi-Klug R, et al
   Long-Term Complications in Youth-Onset Type 2 Diabetes.
   N Engl J Med. 2021;385:416-426.
   PubMed     Abstract available
   
   
   March 2021
2. GIBBONS GH, Seidman CE, Topol EJ
   Conquering Atherosclerotic Cardiovascular Disease - 50 Years of Progress.
   N Engl J Med. 2021;384:785-788.
   PubMed    
   
   
   February 2021
3. RAAL FJ, Gaudet D, Gusarova V
   Evinacumab for Homozygous Familial Hypercholesterolemia. Reply.
   N Engl J Med. 2021;384:e17.
   PubMed    
   
   
   
4. XU HG
   Evinacumab for Homozygous Familial Hypercholesterolemia.
   N Engl J Med. 2021;384:e17.
   PubMed    
   
   
   
5. LUO F, Das A, Fang Z
   Evinacumab for Homozygous Familial Hypercholesterolemia.
   N Engl J Med. 2021;384:e17.
   PubMed    
   
   
   
6. AGIRBASLI M
   Evinacumab for Homozygous Familial Hypercholesterolemia.
   N Engl J Med. 2021;384:e17.
   PubMed    
   
   
   January 2021
7. GAUDET D, Ruzza A, Santos RD
   Evolocumab in Pediatric Heterozygous Familial Hypercholesterolemia. Reply.
   N Engl J Med. 2021;384:84-85.
   PubMed    
   
   
   
8. SINGH A, Mittal S, Kazimuddin M
   Evolocumab in Pediatric Heterozygous Familial Hypercholesterolemia.
   N Engl J Med. 2021;384:84.
   PubMed    
   
   
   December 2020
9. MARTIN SS
   Factoring in ANGPTL3 When LDL Is Refractory.
   N Engl J Med. 2020;383:2385-2386.
   PubMed    
   
   
   November 2020
10. SHAW AT, Bauer TM, de Marinis F, Felip E, et al
    First-Line Lorlatinib or Crizotinib in Advanced ALK-Positive Lung Cancer.
    N Engl J Med. 2020;383:2018-2029.
    PubMed     Abstract available
    
    
    
11. ROSENSON RS, Burgess LJ, Ebenbichler CF, Baum SJ, et al
    Evinacumab in Patients with Refractory Hypercholesterolemia.
    N Engl J Med. 2020 Nov 15. doi: 10.1056/NEJMoa2031049.
    PubMed     Abstract available
    
    
    October 2020
12. DE FERRANTI SD
    Evolocumab in Children with Heterozygous Familial Hypercholesterolemia.
    N Engl J Med. 2020;383:1385-1386.
    PubMed    
    
    
    August 2020
13. SANTOS RD, Ruzza A, Hovingh GK, Wiegman A, et al
    Evolocumab in Pediatric Heterozygous Familial Hypercholesterolemia.
    N Engl J Med. 2020 Aug 29. doi: 10.1056/NEJMoa2019910.
    PubMed     Abstract available
    
    
    
14. KERSTEN S
    Bypassing the LDL Receptor in Familial Hypercholesterolemia.
    N Engl J Med. 2020;383:775-776.
    PubMed    
    
    
    
15. RAAL FJ, Rosenson RS, Reeskamp LF, Hovingh GK, et al
    Evinacumab for Homozygous Familial Hypercholesterolemia.
    N Engl J Med. 2020;383:711-720.
    PubMed     Abstract available
    
    
    April 2020
16. RAY KK, Wright RS, Kallend D, Koenig W, et al
    Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol.
    N Engl J Med. 2020;382:1507-1519.
    PubMed     Abstract available
    
    
    January 2020
17. LUIRINK IK, Kusters DM, Hutten BA
    Statins for Familial Hypercholesterolemia from Childhood. Reply.
    N Engl J Med. 2020;382:488-489.
    PubMed    
    
    
    
18. MURATA Y, Kami M
    Statins for Familial Hypercholesterolemia from Childhood.
    N Engl J Med. 2020;382:488.
    PubMed    
    
    
    
19. BIJL D, Hama R
    Statins for Familial Hypercholesterolemia from Childhood.
    N Engl J Med. 2020;382:487-488.
    PubMed    
    
    
    December 2019
20. WITZTUM JL, Geary RS, O'Dea L
    Volanesorsen, Familial Chylomicronemia Syndrome, and Thrombocytopenia. Reply.
    N Engl J Med. 2019;381:2584.
    PubMed    
    
    
    
21. KHETARPAL SA, Wang M, Khera AV
    Volanesorsen, Familial Chylomicronemia Syndrome, and Thrombocytopenia.
    N Engl J Med. 2019;381:2582-2584.
    PubMed    
    
    
    October 2019
22. MICHOS ED, McEvoy JW, Blumenthal RS
    Lipid Management for the Prevention of Atherosclerotic Cardiovascular Disease.
    N Engl J Med. 2019;381:1557-1567.
    PubMed    
    
    
    
23. LUIRINK IK, Wiegman A, Kusters DM, Hof MH, et al
    20-Year Follow-up of Statins in Children with Familial Hypercholesterolemia.
    N Engl J Med. 2019;381:1547-1556.
    PubMed     Abstract available
    
    
    September 2019
24. MUNOZ D, Uzoije P, Reynolds C, Miller R, et al
    Polypill for Cardiovascular Disease Prevention in an Underserved Population.
    N Engl J Med. 2019;381:1114-1123.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Dyslipidemia is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: